The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 18, 2001

Filed:

Aug. 26, 1999
Applicant:
Inventors:

Akira Mizuno, Kyoto, JP;

Makoto Shibata, Ashikaga, JP;

Tomoe Kamei, Takatsuki, JP;

Harukazu Fukami, Kyoto, JP;

Norio Inomata, Mino, JP;

Assignee:

Suntory Limited, Osaka, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07O / ; A01K 3/154 ;
U.S. Cl.
CPC ...
C07O / ; A01K 3/154 ;
Abstract

A pyrrolesulfonamide compound having formula (I) wherein the ring P represented by &agr; is a pyrrole ring having structure &bgr; or &psgr; wherein A represents alkylene, alkenylene or alkynylene; and Y represents a group &dgr; in which W represents CH, C═ or N; m stands for 0 or 1 when W is CH or N, or m stands for 1 when W is C═; B represents a specific divalent group; E,and E,each independently represents H or lower alkyl; and D represents an aromatic hydrocarbon group or heterocyclic group; l stands for 0 or 1; the dashed line indicates the presence or absence of a bond; and, when the bond is present, Z,is not present and Z,represents H but, when the bond is absent, Z,represents H and Z,represents OH or Z,and Z,are combined together to represent O or a group NOR,, in which R,represents H, or alkyl, aralkyl or aryl; and R represents H, alkyl, cycloalkyl, cycloalkyl-alkyl or aralkyl. The compound (1) has been improved in potency, selectivity to receptors other than serotonin-2 receptors, toxicity, side effects and/or the like over medicines reported to date and equipped with a &agr;,-blocking action and serotonin-2 receptor antagonistic action in combination.


Find Patent Forward Citations

Loading…